BRAF Inhibition and UVB Light Synergistically Promote Mus musculus Papillomavirus 1-Induced Skin Tumorigenesis.

Autor: Dorfer S; Department of Dermatology, Medical University of Vienna, 1090 Vienna, Austria., Ressler JM; Department of Dermatology, Medical University of Vienna, 1090 Vienna, Austria., Riebenbauer K; Department of Dermatology, Medical University of Vienna, 1090 Vienna, Austria., Kancz S; Department of Dermatology, Medical University of Vienna, 1090 Vienna, Austria., Purkhauser K; Department of Dermatology, Medical University of Vienna, 1090 Vienna, Austria., Bachmayr V; Department of Dermatology, Medical University of Vienna, 1090 Vienna, Austria., Cataisson C; Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Kirnbauer R; Department of Dermatology, Medical University of Vienna, 1090 Vienna, Austria., Petzelbauer P; Department of Dermatology, Medical University of Vienna, 1090 Vienna, Austria., Wiesmueller M; Department of Dermatology, Medical University of Vienna, 1090 Vienna, Austria., Egg M; Department of Dermatology, Medical University of Vienna, 1090 Vienna, Austria., Hoeller C; Department of Dermatology, Medical University of Vienna, 1090 Vienna, Austria., Handisurya A; Department of Dermatology, Medical University of Vienna, 1090 Vienna, Austria.

Publikováno v: Cancers [Cancers (Basel)] 2024 Sep 11; Vol. 16 (18). Date of Electronic Publication: 2024 Sep 11.

Dabrafenib plus trametinib in unselected advanced BRAF V600-mut melanoma: a non-interventional, multicenter, prospective trial.

Autor: Richtig E; Department of Dermatology, Medical University of Graz, Graz., Nguyen VA; Department of Dermatology, Medical University of Innsbruck, Innsbruck., Koelblinger P; Department of Dermatology and Allergology, Paracelsus Private Medical University, Salzburg., Wolf I; Department of Dermatology, Medical University of Graz, Graz., Kehrer H; Department of Dermatology, Ordensklinikum Linz Elisabethinen, Linz., Saxinger W; Department of Dermatology, Klinikum Wels-Grieskirchen, Wels., Ressler JM; Department of Dermatology, Medical University of Vienna, Vienna., Weinlich G; Department of Dermatology, Medical University of Innsbruck, Innsbruck., Meyersburg D; Department of Dermatology and Allergology, Paracelsus Private Medical University, Salzburg., Hafner C; Department of Dermatology, University Hospital St. Pölten, Karl Landsteiner University of Health Sciences, St Pölten., Jecel-Grill E; Department of Dermatology, University Hospital St. Pölten, Karl Landsteiner University of Health Sciences, St Pölten., Kofler J; Department of Dermatology, Klinikum Klagenfurt am Wörthersee, Klagenfurt., Lange-Asschenfeldt B; Department of Dermatology, Klinikum Klagenfurt am Wörthersee, Klagenfurt., Weihsengruber F; Department of Dermatology and Venereology, Rudolfstiftung Hospital, Vienna., Rappersberger K; Department of Dermatology and Venereology, Rudolfstiftung Hospital, Vienna., Svastics N; Dermatologische Ambulanz, Landesklinikum Wiener Neustadt, Wiener Neustadt., Gasser K; Department of Oncology and Hematology, LKH Feldkirch, Rankweil., Seeber A; Department of Dermatology, SMZ Ost, Vienna., Kratochvill F; Novartis Pharma GmbH, Vienna, Austria., Nagler S; Novartis Pharma GmbH, Vienna, Austria., Mraz B; Novartis Pharma GmbH, Vienna, Austria., Hoeller C; Department of Dermatology, Medical University of Vienna, Vienna.

Publikováno v: Melanoma research [Melanoma Res] 2024 Apr 01; Vol. 34 (2), pp. 142-151. Date of Electronic Publication: 2023 Dec 13.

DNA Methylation Signatures Correlate with Response to Immune Checkpoint Inhibitors in Metastatic Melanoma.

Autor: Ressler JM; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Tomasich E; Department of Medicine I, Division of Oncology, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Hatziioannou T; Department of Medicine I, Division of Oncology, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Ringl H; Wiener Gesundheitsverbund, Klinik Donaustadt, Vienna, Austria., Heller G; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Silmbrod R; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Gottmann L; Department of Medicine I, Division of Oncology, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Starzer AM; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Zila N; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Division of Biomedical Science, University of Applied Sciences FH Campus Wien, Vienna, Austria., Tschandl P; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Hoeller C; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Preusser M; Department of Medicine I, Division of Oncology, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Berghoff AS; Department of Medicine I, Division of Oncology, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. anna.berghoff@meduniwien.ac.at.; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria. anna.berghoff@meduniwien.ac.at.

Publikováno v: Targeted oncology [Target Oncol] 2024 Mar; Vol. 19 (2), pp. 263-275. Date of Electronic Publication: 2024 Feb 24.

Comparison of humans versus mobile phone-powered artificial intelligence for the diagnosis and management of pigmented skin cancer in secondary care: a multicentre, prospective, diagnostic, clinical trial.

Autor: Menzies SW; Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. Electronic address: scott.menzies@bigpond.com., Sinz C; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Menzies M; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Skintography, Sydney, NSW, Australia., Lo SN; Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia., Yolland W; MetaOptima Technology, Vancouver, BC, Canada., Lingohr J; MetaOptima Technology, Vancouver, BC, Canada., Razmara M; MetaOptima Technology, Vancouver, BC, Canada., Tschandl P; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Guitera P; Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Scolyer RA; Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia., Boltz F; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Borik-Heil L; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Herbert Chan H; Department of Dermatology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Chromy D; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Coker DJ; Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Collgros H; Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Eghtedari M; Department of Dermatology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Corral Forteza M; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Forward E; Department of Dermatology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Gallo B; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Geisler S; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Gibson M; Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Department of Dermatology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Hampel A; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Ho G; Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Department of Dermatology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Junez L; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Kienzl P; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Martin A; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia., Moloney FJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Regio Pereira A; Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Ressler JM; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Richter S; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Silic K; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Silly T; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Skoll M; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Tittes J; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Weber P; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Weninger W; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Weiss D; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Woo-Sampson P; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Zilberg C; Department of Dermatology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Kittler H; Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Publikováno v: The Lancet. Digital health [Lancet Digit Health] 2023 Oct; Vol. 5 (10), pp. e679-e691.

Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland.

Autor: Schumann K; Department of Dermatology and Allergy, School of Medicine, German Cancer Consortium (DKTK), Technical University of Munich, Munich, Germany., Mauch C; Department for Dermatology and Venereology and CIO ABCD, University Hospital Köln, Köln, Germany., Klespe KC; Department for Dermatology and Venereology and CIO ABCD, University Hospital Köln, Köln, Germany., Loquai C; Department for Dermatology, Johannes Gutenberg-University Mainz, Mainz, Germany., Nikfarjam U; Department for Dermatology, Johannes Gutenberg-University Mainz, Mainz, Germany., Schlaak M; Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Akçetin L; Department for Dermatology and Allergy, Ludwig-Maximilian University, Munich, Germany., Kölblinger P; Department for Dermatology and Allergology, Paracelsus Medical University, Salzburg, Austria., Hoellwerth M; Department for Dermatology and Allergology, Paracelsus Medical University, Salzburg, Austria., Meissner M; Department for Dermatology, University Clinic Frankfurt, Frankfurt, Germany., Mengi G; Department for Dermatology, University Clinic Frankfurt, Frankfurt, Germany., Braun AD; Department of Dermatology, University Hospital Magdeburg, Magdeburg, Germany., Mengoni M; Department of Dermatology, University Hospital Magdeburg, Magdeburg, Germany., Dummer R; Dermatology Clinic, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Mangana J; Dermatology Clinic, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Sindrilaru MA; Department for Dermatology and Allergy, University Clinic Ulm, Ulm, Germany., Radmann D; Department for Dermatology and Allergy, University Clinic Ulm, Ulm, Germany., Hafner C; Department of Dermatology, University Hospital St. Pölten, Karl Landsteiner University of Health Sciences, St. Pölten, Austria., Freund J; Department of Dermatology, University Hospital St. Pölten, Karl Landsteiner University of Health Sciences, St. Pölten, Austria., Rappersberger K; Department for Dermatology, Municipal Hospital Landstrasse, Vienna, Austria., Weihsengruber F; Department for Dermatology, Municipal Hospital Landstrasse, Vienna, Austria., Meiss F; Department for Dermatology and Venereology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany., Reinhardt L; Skin Cancer Center at the University Cancer Centre Dresden and National Center for Tumor Diseases, Dresden, Germany.; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany., Meier F; Skin Cancer Center at the University Cancer Centre Dresden and National Center for Tumor Diseases, Dresden, Germany.; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany., Rainer B; Department of Dermatology and Venereology, Medical University Graz, Graz, Austria., Richtig E; Department of Dermatology and Venereology, Medical University Graz, Graz, Austria., Ressler JM; Department of Dermatology, Medical University Vienna, Vienna, Austria., Höller C; Department of Dermatology, Medical University Vienna, Vienna, Austria., Eigentler T; Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Dermatology, Interdisciplinary Skin Cancer Center, University Medical Center Tuebingen, Tuebingen, Germany., Amaral T; Department of Dermatology, Interdisciplinary Skin Cancer Center, University Medical Center Tuebingen, Tuebingen, Germany., Peitsch WK; Departments of Dermatology and Phlebology, Vivantes Skin Cancer Center, Vivantes Clinic Friedrichshain, Neukölln and Spandau, Berlin, Germany., Hillen U; Department of Dermatology and Venereology, Vivantes Skin Cancer Center, Klinikum Neukölln, Berlin, Germany., Harth W; Department of Dermatology and Allergology, Vivantes Skin Cancer Center, Klinikum Spandau, Berlin, Germany., Ziller F; Department for Dermatology, DRK Hospital Chemnitz-Rabenstein, Chemnitz, Germany., Schatton K; Department for Dermatology, University Clinic Düsseldorf, Düsseldorf, Germany., Gambichler T; Department of Dermatology, Skin Cancer Center, Ruhr-University Bochum, Bochum, Germany., Susok L; Department of Dermatology, Skin Cancer Center, Ruhr-University Bochum, Bochum, Germany., Maul LV; Department for Dermatology, University Hospital Basel, Basel, Switzerland., Läubli H; Department for Oncology, University Hospital Basel, Basel, Switzerland., Debus D; Department of Dermatology, Nuremberg General Hospital - Paracelsus Medical University, Nuremberg, Germany., Weishaupt C; Department for Dermatology and Venereology, University Clinic Münster, Münster, Germany., Börger S; Clinic for Dermatology, Kassel, Germany., Sievers K; Clinic for Dermatology, Kassel, Germany., Haferkamp S; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany., Zenderowski V; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany., Nguyen VA; Department for Dermatology, Venereology and Allergology, Medical University Innsbruck, Innsbruck, Austria., Wanner M; Department for Dermatology, Venereology and Allergology, Medical University Innsbruck, Innsbruck, Austria., Gutzmer R; Department of Dermatology, Mühlenkreiskliniken Minden und Ruhr University Bochum, Minden, Germany., Terheyden P; Department for Dermatology and Venereology, University Clinic Schleswig-Holstein, Lübeck, Germany., Kähler K; Department for Dermatology and Venereology, University Clinic Schleswig-Holstein, Kiel, Germany., Emmert S; Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Rostock, Germany., Thiem A; Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Rostock, Germany., Sachse M; Department for Dermatology, Clinic Bremerhaven Reinkenheide, Bremerhaven, Germany., Gercken-Riedel S; Department for Dermatology, Clinic Bremerhaven Reinkenheide, Bremerhaven, Germany., Kaune KM; Dermatology, Dermatosurgery and Allergology Clinic, Bremen-Mitte Hospital, Bremen, Germany., Thoms KM; Department for Dermatology, University Hospital Göttingen, Georg-August-University, Göttingen, Germany., Heinzerling L; Department for Dermatology and Allergy, Ludwig-Maximilian University, Munich, Germany.; Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander University Erlangen-Nürnberg and Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg, Erlangen, Germany., Heppt MV; Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander University Erlangen-Nürnberg and Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg, Erlangen, Germany., Tratzmiller S; Department for Dermatology, Municipal Hospital Karlsruhe, Karlsruhe, Germany., Hoetzenecker W; Department of Dermatology, University Hospital Linz, Johannes Kepler University, Linz, Austria., Öllinger A; Department of Dermatology, University Hospital Linz, Johannes Kepler University, Linz, Austria., Steiner A; Municipal Hospital Hietzing, Vienna, Austria., Peinhaupt T; Municipal Hospital Hietzing, Vienna, Austria., Podda M; Department for Dermatology, Clinic Darmstadt, Darmstadt, Germany., Schmid S; Department for Dermatology, Clinic Darmstadt, Darmstadt, Germany., Wollina U; Department for Dermatology and Allergology, Municipal Hospital Dresden, Dresden, Germany., Biedermann T; Department of Dermatology and Allergy, School of Medicine, German Cancer Consortium (DKTK), Technical University of Munich, Munich, Germany., Posch C; Department of Dermatology and Allergy, School of Medicine, German Cancer Consortium (DKTK), Technical University of Munich, Munich, Germany.; Faculty of Medicine, Sigmund Freud University Vienna, Vienna, Austria.; Department for Dermatology, Clinic Hietzing, Vienna Healthcare Group, Vienna, Austria.

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2023 May; Vol. 37 (5), pp. 894-906. Date of Electronic Publication: 2022 Dec 12.